FDA alignment on a single-dose Phase 3 study design and potential single-trial registration pathway further strengthens the ...
Strange beings lurk in pixelated places, eyes peep from dark spaces, and seemingly random objects confront curious travelers.
RNA has emerged as one of the most promising molecules in modern medicine, enabling advances from mRNA vaccines and gene ...
16h
Australian cancer trials are getting worse at reporting sex differences, putting patients at risk
Women with cancer may not have the same chance of cure or quality of life as men—yet fewer than 2% of Australian cancer ...
Merck, a leading science and technology company, today announced that the US Food and Drug Administration (FDA) has granted ...
Endogenex, a clinical-stage medical device company dedicated to improving outcomes in individuals with type 2 diabetes (T2D), announced that the ReCET Clinical Study has reached full enrollment. A ...
Lynk Pharmaceuticals dosed its first patient in a Phase II clinical trial testing LNK01004 ointment for vitiligo, advancing ...
Environmental sustainability in tertiary sports remains an emergent yet under-resourced domain, particularly in sub-Saharan ...
Kura Oncology is positioning ziftomenib (KOMZIFTI) as a combination backbone in AML, not just a relapsed/refractory ...
Interesting Engineering on MSN
New in-memory computing chip promises faster processing with lower energy use
Artificial intelligence chip developers SK hynix and TetraMem have demonstrated a new memory-centric processor ...
You are in the mood to keep life balanced today, but people around you might test your patience a little. Expect chats, calls ...
Explore why men grow beards beyond fashion trends. Discover the psychological impacts of facial hair on perceptions of age, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results